Picture of BioNano Genomics logo

BNGO BioNano Genomics Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Momentum

Relative Strength (%)
1m+104.36%
3m+108.09%
6m+69.05%
1yr-36.95%
Volume Change (%)
10d/3m+147.33%
Price vs... (%)
52w High-42.67%
50d MA+101.07%
200d MA+44.94%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-37.97%
Return on Equity-33.56%
Operating Margin-478%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of BioNano Genomics EPS forecast chart

Profile Summary

Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sell the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
January 24th, 2003
Public Since
August 1st, 2018
No. of Shareholders
108
No. of Employees
299
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
290,139,940

BNGO Share Price Performance

Upcoming Events for BNGO

Q3 2022 Bionano Genomics Inc Earnings Release

Similar to BNGO

Picture of Accelerate Diagnostics logo

Accelerate Diagnostics

us flag iconNASDAQ Capital Market

Picture of Adapthealth logo

Adapthealth

us flag iconNASDAQ Capital Market

Picture of Aethlon Medical logo

Aethlon Medical

us flag iconNASDAQ Capital Market

Picture of Agendia NV logo

Agendia NV

us flag iconNASDAQ Capital Market

Picture of Allied Healthcare Products logo

Allied Healthcare Products

us flag iconNASDAQ Capital Market

FAQ

Or unlock with your email

Or unlock with your email